title: Sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a meta-analysis.
abstract: OBJECTIVE
  It is controversial that whether sleeve lobectomy (SL) should be promoted more worthy than pneumonectomy (PN) in suitable patients.
  
  
  METHODS
  We searched all studies that had been published in English from PUBMED and Embase which compared the short-term and long-term outcomes of SL and pneumonectomy (PN) in patients with non-small cell lung cancer (NSCLC).
  
  
  RESULTS
  Nineteen studies met our criteria with a combined total of 3878 subjects, of which 1316 (33.9%) underwent SL and 2562 (66.1%) underwent PN. The odds ratio was 0.50 (95% CI: 0.34-0.72) for postoperative mortality, 1.17 (95% CI: 0.82-1.67) for postoperative complications, 0.78 (95% CI: 0.47-1.29) for locoregional recurrences. The risk difference for 1-, 3-, 5- year was 0.11 (95% CI: 0.07-0.14), 0.15 (95% CI: 0.06-0.24), 0.15 (95% CI: 0.09-0.20),respectively. The pooled hazard ratio was 0.63 (95% CI: 0.56-0.71) in favor of SL group.
  
  
  CONCLUSIONS
  SL is more worthy to be done than PN in suitable patients with less mortality and better long-term survival.
authors.affiliation: Department of Cardio-Thoracic Surgery, the third People’s hospital, Yancheng, China.
authors.forename: Woda
authors.initials: W
authors.lastname: Shi
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Haoliang
authors.initials: H
authors.lastname: Sun
authors.forename: Yongfeng
authors.initials: Y
authors.lastname: Shao
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000601:surgery*; D015233:Models, Statistical; D009364:Neoplasm Recurrence, Local; D016017:Odds Ratio; D018579:Patient Selection; D011013:Pneumonectomy / Q000379:methods* / Q000401:mortality; D011183:Postoperative Complications / Q000453:epidemiology; D015996:Survival Rate; D016896:Treatment Outcome